Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04267874Phase 1Completed
Phase 1, randomised, double-blind trial (2 arms), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoints: Recruitment rates up to 3 years, Study adherence up to 3 years and 3 more. Started Oct 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04267874.